IFN-γ-derived lipopeptides: Influence of lipid modification on the conformation and the ability to induce MHC class II expression on murine and human cells

Journal of Medicinal Chemistry

Volumn 42, Issue 18, 1999, Pages 3732-3736

  Thiam, Kader ^a   Loing, Estelle ^a   Verwaerde, Claudie ^a   Auriault, Claude ^a   Gras Masse, Hélène ^a  

^a UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE RECEPTOR; GAMMA INTERFERON RECEPTOR; LIPOPEPTIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; DRUG DELIVERY SYSTEM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; RECEPTOR BINDING; SPLEEN CELL;

ADJUVANTS, IMMUNOLOGIC; AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; CIRCULAR DICHROISM; FLUORESCENT ANTIBODY TECHNIQUE; GENES, MHC CLASS II; HUMANS; INTERFERON TYPE II; LIPIDS; LIPOPROTEINS; MICE; MICROSCOPY, FLUORESCENCE; MOLECULAR CONFORMATION; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDES;

EID: 0033539052     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm991025f     Document Type: Article

References (28)

1. Heath, A. Cytokines as immulogical Adjuvants. Vaccine design: The subunit and Adjuvant Approach. In Pharmaceutical Biotechnology; Powell, M. F., Newman, M. J., Eds.; Plenum Press: New York, 1995; Vol. 6, pp 645-658.
2. Heath, A. W.; Playfair, J. L. H. Cytokines as immunological adjuvants. Vaccine 1993, 7, 427-434.
3. Playfair, J. L. H.; DeSouza J. B. Recombinant interferon-γ is a potent y adjuvant for a malaria vaccine in mice. Clin. Exp. Immunol. 1987, 67, 5-10.
4. Quiroga, J. A.; Castillo, I.; Porres, J. C.; Casado, S.; Saez, F.; Gracia-Martinez, M.; Gómez, M.; Inglada, L.; Sánchez-Sicilia, L.; Mora, A.; et al. Recombinant γ-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients. Hepatology 1990, 12, 661-663.
5. Heath, A. W.; Playfair, J. L. H. Conjunction of interferon-γ to antigen enhances its adjuvanticity. Immunology 1990, 71, 454-456.
6. Hudkins, R. L.; Diebold, J. L.; Angeles, T. S.; Knight, E., Jr. Fused pyrrolo[2,3-c]carbazol-6-ones: novel immunostimulants that enhance human interferon-γ activity. J. Med. Chem. 1997, 40 (19), 2994-2996.
7. Bazan, J. F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 6934-6938.
8. Aguet, M.; Dembic, Z.; Merlin, G. Molecular cloning and expression of the human interferon-γ receptor. Cell 1988, 55 (2), 273-280.
9. Jarpe, M. A.; Johnson, H. M. Topology of receptor binding domains of mouse IFN-γ. J. Immunol. 1990, 145, 3304-3309.
10. Szente, B. E.; Johnson, H. M. Binding of IFN-γ and its C-terminal peptide to a cytoplasmic domain of its receptor that is essential for function. Biochem. Biophys. Res. Commun. 1994, 207, 215-221.
11. Szente, B. E.; Subramaniam, P. S.; Johnson, H. M. Indentification of IFN-γ receptor binding sites for JAK2 and enhancement of binding by IFN-γ and its C-tenninal peptide IFN-γ (95-133). J. Immunol. 1995, 155, 5617-5622.
12. Fidler, I. J.; Fogler, W. E.; Kleinerman, E.; Saiki, S. I. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-γ encapsulated in liposomes. J. Immunol. 1985, 135, 4289-4296.
13. Smith, M. R.; Muegge, K.; Keller, J. R.; Kung, H.-F.; Young, H. A.; Durum, S. K. Direct evidence for an intracellular role for IFN-γ. J. Immunol. 1990, 144, 1777-1782.
14. Sanceau, J.; Sondermeyer, P.; Beranger, F.; Falcoff, R.; Vaquero, C. Intracellular human γ-interferon triggers an antiviral state in transformed murine L cells. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 2906-2910.
15. Will, A.; Hemmann, U.; Horn, F.; Rollinghoff, M.; Gessner, A. Intracellular murine IFN-γ mediates virus resistance, expression of oligoadenylate synthetase, and activation of STAT transcription factors. J. Immunol. 1996, 757, 4576-4583.
16. Soh, J.; Donnelli, R. J.; Kotenko, S.; Mariano, T. M.; Cook, J. R.; Wang, N.; Emmanuel, S.; Schwartz, B.; Miki, T.; Pestka, S. Identification and sequence of an accessory factor requiered for activation of the human interferon-γ receptor. Cell 1994, 76 (5), 793-802.
17. Hemmi, S.; Bohni, R.; Stark, G.; Di Marco, F.; Aguet, M. A novel member of the interferon receptor family complements functionality of the murine interferon-γ receptor in human cells. Cell 1994, 76 (5), 803-810.
18. Szente, B. E.; Soos, J. M.; Johnson, H. The C-terminus of IFN-γ is sufficient for intracellular function. Biochem. Biophys. Res. Commun. 1994, 203, 1645-1654.
19. Szente, B. E.; Jweiner, I. J.; Jablonsky, M. J.; Krishna, B. A.; Johnson, H. Structural requirements for agonist activity of a Murine Interferon-γ peptide. J. Interferon Cytokine Res. 1996, 16, 813-817.
20. Loing, E.; Delanoye, A.; Sergheraert, C.; Tartar, A.; Gras-Masse, H. Assessing delivery of lipopeptide into the cytoplasm of intact cells by a functional assay based on PKC inhibition. The Jurkat model. Pept. Res. 1996, 9, 229-232.
21. Thiam, K.; Loing, E.; Gilles, F.; Verwaerde, C.; Quatannens, B.; Auriault, C.; Gras-Masse, H. Induction of apoptosis by protein kinase C pseudosubstrate lipopeptides in several human cells. Lett. Pept. Sci. 1997, 4, 397-402.
22. Thiam, K.; Loing, E.; Delanoye, A.; Diesis, E.; Gras-Masse, H.; Auriault, C.; Verwaerde, C. Unrestricted agonist activity on murine and human cells of a lipopeptide deived from IFN-γ. Biophys. Res. Commun. 1998, 253 (3), 639-647.
23. Laczko, I.; Hollosi, M.; Vass, E.; Toth, G. K. Liposome-induced conformational changes of an epitopic peptide and its palmitoylated derivative of influenza virus hemagglutinin. Biochem. Biophys. Res. Commun. 1998, 249 (1), 213-217.
24. Niidome, T.; Kawakami, R.; Okamoto, K.; Ohmori, N.; Mihara, H.; Aoyagi, H. Interaction of lipophilic peptides derived from mastoparan with phospholipid vesicles. J. Pept. Res. 1997, 50 (6), 458-464.
25. Ealick, S. E.; Cook, W. J.; Vijay-Kumar, S.; Carson, M.; Nagabhusan, T. L.; Trotta, P. P.; Bugg, C. E. Three-dimensionnal structure of the human recombinant interferon-γ. Science 1991, 252, 698-702.
26. Mortara, L.; Gras-Masse, H.; Rommens, C.; Venet, A.; Guillet, L. G.; Bourgault-Villada, I. Induction of strong anti-peptide multispecific CTL in Rhesus Macaques by immunization with lipopeptides including a promiscuous T helper epitope. J. Virol., submitted.
27. Fields, G. B.; Noble, R. L. Solid-phase peptide synthesis utilizing 9-fluorenylmethoxy carbonyl amino acids. Int. J. Pept. Protein Res. 1990, 35, 161-214.
28. Merrifield, R. B. Solid-phase synthesis. Science. 1986, 232, 341-347.